Psychoneuroendocrinology
Volume 35, Issue 3 , Pages 369-381 , April 2010

Neonatal bacterial infection alters fever to live and simulated infections in adulthood

  • Staci D. Bilbo

      Affiliations

    • Department of Psychology and Neuroscience, Duke University, Durham, NC 27708, United States
    • Corresponding Author InformationCorresponding author at: Department of Psychology and Neuroscience, Duke University, 572 Research Drive, 3016 GSRB II, Durham, NC 27708, United States. Tel.: +1 919 681 7005; fax: +1 919 660 5798.
    • ,
  • Julie L. Wieseler

      Affiliations

    • Department of Psychology, University of Colorado, Boulder, CO 80309, United States
    • ,
  • Ruth M. Barrientos

      Affiliations

    • Department of Psychology, University of Colorado, Boulder, CO 80309, United States
    • ,
  • Verne Tsang

      Affiliations

    • Department of Psychology and Neuroscience, Duke University, Durham, NC 27708, United States
    • ,
  • Linda R. Watkins

      Affiliations

    • Department of Psychology, University of Colorado, Boulder, CO 80309, United States
    • ,
  • Steven F. Maier

      Affiliations

    • Department of Psychology, University of Colorado, Boulder, CO 80309, United States

Received 20 February 2009 ,Revised 20 July 2009 ,Accepted 21 July 2009.

References 

  1. Adib-Conquy M, Cavaillon JM. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J. Biol. Chem. 2002;277:27927–27934
  2. Arbibe L, Sansonetti PJ. Epigenetic regulation of host response to LPS: causing tolerance while avoiding Toll errancy. Cell Host Microbe. 2007;1:244–246
  3. Barker DJ, Gluckman PD, Robinson JS. Conference report: fetal origins of adult disease—report of the First International Study Group, Sydney, 29–30 October 1994. Placenta. 1995;16:317–320
  4. Berczi I. Neurohormonal host defense in endotoxin shock. Ann. N. Y. Acad. Sci. 1998;840:787–801
  5. Bilbo SD, Barrientos RM, Eads AS, Northcutt A, Watkins LR, Rudy JW, et al. Early-life infection leads to altered BDNF and IL-1beta mRNA expression in rat hippocampus following learning in adulthood. Brain Behav. Immun. 2008;22:451–455
  6. Bilbo SD, Biedenkapp JC, Der-Avakian A, Watkins LR, Rudy JW, Maier SF. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 2005;25:8000–8009
  7. Bilbo SD, Levkoff LH, Mahoney JH, Watkins LR, Rudy JW, Maier SF. Neonatal infection induces memory impairments following an immune challenge in adulthood. Behav. Neurosci. 2005;119:293–301
  8. Bilbo SD, Newsum NJ, Sprunger DB, Watkins LR, Rudy JW, Maier SF. Differential effects of neonatal handling on early life infection-induced alterations in cognition in adulthood. Brain Behav. Immun. 2007;21:332–342
  9. Bilbo SD, Rudy JW, Watkins LR, Maier SF. A behavioural characterization of neonatal infection-facilitated memory impairment in adult rats. Behav. Brain Res. 2006;169:39–47
  10. Bilbo SD, Yirmiya R, Amat J, Paul ED, Watkins LR, Maier SF. Bacterial infection early in life protects against stressor-induced depressive-like symptoms in adult rats. Psychoneuroendocrinology. 2008;33:261–269
  11. Boisse L, Mouihate A, Ellis S, Pittman QJ. Long-term alterations in neuroimmune responses after neonatal exposure to lipopolysaccharide. J. Neurosci. 2004;24:4928–4934
  12. Breivik T, Stephan M, Brabant GE, Straub RH, Pabst R, von Horsten S. Postnatal lipopolysaccharide-induced illness predisposes to periodontal disease in adulthood. Brain Behav. Immun. 2002;16:421–438
  13. Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological “damage limitation” effect and an important potential opportunity for therapy. Curr. Med. Chem. 2006;13:2487–2502
  14. Campisi J, Hansen MK, O’Connor KA, Biedenkapp JC, Watkins LR, Maier SF, et al. Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge. J. Appl. Physiol. 2003;95:1873–1882
  15. Cao C, Matsumura K, Yamagata K, Watanabe Y. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res. 1995;697:187–196
  16. Cavaillon JM. The nonspecific nature of endotoxin tolerance. Trends Microbiol. 1995;3:320–324
  17. Chakravarty S, Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 2005;25:1788–1796
  18. Chemo A, Fraifeld V, Adramovich L, Sod-Moriah UA, Kaplanski J. Tolerance to lipopolysaccharide is not related to the ability of the hypothalamus to produce prostaglandin E2. Life Sci. 1997;61:813–818
  19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal. Biochem. 1987;162:156–159
  20. Dalpke AH, Lehner MD, Hartung T, Heeg K. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology. 2005;116:203–212
  21. Ellis S, Mouihate A, Pittman QJ. Early life immune challenge alters innate immune responses to lipopolysaccharide: implications for host defense as adults. FASEB J. 2005;19:1519–1521
  22. Ellis S, Mouihate A, Pittman QJ. Neonatal programming of the rat neuroimmune response: stimulus specific changes elicited by bacterial and viral mimetics. J. Physiol. 2006;571:695–701
  23. Elmquist JK, Breder CD, Sherin JE, Scammell TE, Hickey WF, Dewitt D, et al. Intravenous lipopolysaccharide induces cyclooxygynase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J. Comp. Neurol. 1997;381:119–129
  24. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 2004;10:71–84
  25. Fejer G, Szalay K, Gyory I, Fejes M, Kusz E, Nedieanu S, et al. Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock. J. Immunol. 2005;175:1498–1506
  26. Felton LM, Cunningham C, Rankine EL, Waters S, Boche D, Perry VH. MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease. Neurobiol. Dis. 2005;20:283–295
  27. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007;447:972–978
  28. Ge Y, Ezzell RM, Clark BD, Loiselle PM, Amato SF, Warren HS. Relationship of tissue and cellular interleukin-1 and lipopolysaccharide after endotoxemia and bacteremia. J. Infect. Dis. 1997;176:1313–1321
  29. Geisel J, Kahl F, Muller M, Wagner H, Kirschning CJ, Autenrieth IB, et al. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells. J. Immunol. 2007;179:5811–5818
  30. Glaser J, Greene G, Hendricks S. Stereology for Biological Research. Williston, VT: MBF Press; 2007;
  31. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem. Immunol. 1999;72:7–29
  32. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410:1099–1103
  33. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740–745
  34. Hirohashi N, Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect. Immun. 1996;64:1011–1015
  35. Hornig M, Weissenbock H, Horscroft N, Lipkin WI. An infection-based model of neurodevelopmental damage. Proc. Natl. Acad. Sci. U.S.A. 1999;96:12102–12107
  36. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow Metab. 2002;22:308–317
  37. Ivanov AI, Kulchitsky VA, Sugimoto N, Simons CT, Romanovsky AA. Does the formation of lipopolysaccharide tolerance require intact vagal innervation of the liver?. Auton. Neurosci. 2000;85:111–118
  38. Ivanov AI, Romanovsky AA. Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front. Biosci. 2004;9:1977–1993
  39. Johnson JD, Fleshner M. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72. J. Leukoc. Biol. 2006;79:425–434
  40. Lehner MD, Ittner J, Bundschuh DS, van Rooijen N, Wendel A, Hartung T. Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect. Immun. 2001;69:463–471
  41. Li MH, Seatter SC, Manthei R, Bubrick M, West MA. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J. Surg. Res. 1994;57:85–92
  42. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–408
  43. Matsumura K, Kobayashi S. Signaling the brain in inflammation: the role of endothelial cells. Front. Biosci. 2004;9:2819–2826
  44. Moreland JG, Bailey G, Nauseef WM, Weiss JP. Organism-specific neutrophil–endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. J. Immunol. 2004;172:426–432
  45. Mouton PR. Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists. JHU Press; 2002;
  46. Nansen A, Randrup Thomsen A. Viral infection causes rapid sensitization to lipopolysaccharide: central role of IFN-alpha beta. J. Immunol. 2001;166:982–988
  47. Parmely MJ, Wang F, Wright D. Gamma interferon prevents the inhibitory effects of oxidative stress on host responses to Escherichia coli infection. Infect. Immun. 2001;69:2621–2629
  48. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45
  49. Quan N, Whiteside M, Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res. 1998;802:189–197
  50. Rankine EL, Hughes PM, Botham MS, Perry VH, Felton LM. Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur. J. Neurosci. 2006;24:77–86
  51. Rayhane N, Fitting C, Lortholary O, Dromer F, Cavaillon JM. Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect. Immun. 2000;68:3748–3753
  52. Schiltz JC, Sawchenko PE. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 2002;22:5606–5618
  53. Shanks N, Windle RJ, Perks PA, Harbuz MS, Jessop DS, Ingram CD, et al. Early-life exposure to endotoxin alters hypothalamic–pituitary–adrenal function and predisposition to inflammation. Proc. Natl. Acad. Sci. U.S.A. 2000;97:5645–5650
  54. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003;23:297–302
  55. Steiner AA, Chakravarty S, Robbins JR, Dragic AS, Pan J, Herkenham M, et al. Thermoregulatory responses of rats to conventional preparations of lipopolysaccharide are caused by lipopolysaccharide per se—not by lipoprotein contaminants. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;289:R348–R352
  56. Steiner AA, Chakravarty S, Rudaya AY, Herkenham M, Romanovsky AA. Bacterial lipopolysaccharide fever is initiated via Toll-like receptor 4 on hematopoietic cells. Blood. 2006;107:4000–4002
  57. Steiner AA, Ivanov AI, Serrats J, Hosokawa H, Phayre AN, Robbins JR, et al. Cellular and molecular bases of the initiation of fever. PLoS Biol. 2006;4:e284
  58. Walker FR, Hodyl NA, Krivanek KM, Hodgson DM. Early life host–bacteria relations and development: long-term individual differences in neuroimmune function following neonatal endotoxin challenge. Physiol. Behav. 2006;87:126–134
  59. West MA, Heagy W. Endotoxin tolerance: a review. Crit. Care Med. 2002;30:S64–73
  60. West MA, Li MH, Seatter SC, Bubrick MP. Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages. J. Trauma. 1994;37:82–89(discussion 89–90)
  61. Zuckerman SH, Evans GF, Butler LD. Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression. Infect. Immun. 1991;59:2774–2780

PII: S0306-4530(09)00242-X

doi: 10.1016/j.psyneuen.2009.07.014

Psychoneuroendocrinology
Volume 35, Issue 3 , Pages 369-381 , April 2010

Article Tools

* Image Usage & Resolution